🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
56.28
-1.83 (-3.15%)
Nov 19, 2026, 4:00 PM EST - Market closed

Inspire Medical Systems Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, Inspire Medical Systems stock has a consensus rating of "Hold" and an average price target of $69.38. The average 1-year stock price forecast is 23.28% higher than the current stock price, while the lowest is $45 (-20.04%) and the highest is $93 (+65.25%).

Price Target: $69.38 (+23.28%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$45$69.38$69.5$93
Change-20.04%+23.28%+23.49%+65.25%

Analyst Ratings

The average analyst rating for Inspire Medical Systems stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy334444
Buy000000
Hold121211111111
Sell111122
Strong Sell011111
Total161717171818

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Sell
Maintains
$40 → $45
SellMaintains$40 → $45-20.04%Nov 6, 2026
Oppenheimer
Oppenheimer
Buy
Maintains
$85
BuyMaintains$85+51.03%Nov 3, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Reiterates
$85
BuyReiterates$85+51.03%Nov 3, 2026
RBC Capital
RBC Capital
Hold
Maintains
$75
HoldMaintains$75+33.26%Nov 3, 2026
J.P. Morgan
J.P. Morgan
Hold
Reiterates
$60 → $65
HoldReiterates$60 → $65+15.49%Nov 3, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
855.20M
from 911.98M
Decreased by -6.23%
Revenue Next Year
876.34M
from 855.20M
Increased by 2.47%
EPS This Year
1.30
from 2.42
Decreased by -46.23%
EPS Next Year
1.50
from 1.30
Increased by 14.91%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
233.39M407.86M624.80M802.80M911.98M855.20M
Revenue Growth
102.28%74.75%53.19%28.49%13.60%-6.23%
Gross Profit
200.12M341.74M528.22M679.82M778.76M737.21M
Gross Margin
85.74%83.79%84.54%84.68%85.39%86.20%
Operating Income
-39.85M-47.59M-40.27M36.08M50.95M40.35M
Net Income
-42.04M-44.88M-21.15M53.51M145.42M-8.26M
EPS
----2.421.30
EPS Growth
----38.29%-46.23%
Forward PE
---114.3757.1443.25
Free Cash Flow
----78.48M119.68M
No. Analysts
-----17
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High858.1M
Avg855.2M
Low850.1M

Revenue Growth

Revenue Growth202620272028
High
-5.9%
Avg
-6.2%
Low
-6.8%

EPS Forecast

EPS202620272028
High1.35
Avg1.30
Low1.23

EPS Growth

EPS Growth202620272028
High
-44.2%
Avg
-46.2%
Low
-49.2%